Health Condition 1: null- pregnant women with Iron deficiency anemia
Conditions
Interventions
Intervention1: Iron sucrose injections: In group B (intravenous group), women will be admitted for a short duration for the treatment. The total iron dose to be administered will be calculated as foll
0.24 is a correction factor taking into account the patientâ??s blood volume and hemoglobin iron content and 500 mg was for the restoration of iron stores. This total dose will be rounded up to the ne
Sponsors
Dr RPGMC Kangra HP
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >18 years 2. Singleton pregnancy between 24â??34 weeks of gestation, 3. Moderate iron deficiency anemia (hemoglobin 7.0â??9.0 g/dL), 4. Mean corpuscular volume 5. Serum ferritin level 6. Negative naked eye single tube red cell osmotic fragility test (NESTROFT) 7. No associated obstetric or medical complications.
Exclusion criteria
Exclusion criteria: 1. Anemia due to any cause other than iron deficiency 2. Severe anemia (Hb 3. Asthma, viral hepatitis, cirrhosis, cardiovascular disease, autoimmune disease, suspected acute infection 4. Intolerance to iron derivatives 5. Women who had received parenteral iron treatment earlier (last 6 months) 6. Not willing to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measure is efficacy of treatment, (determined by studying the rate of improvement in both the groups (by comparing the changes with the baseline values of Hb, MCV, MCH, MCHC and reticulocyte count on days 14, and 30. On day 30, changes in peripheral smear and serum ferritin will also be recorded.) Timepoint: from onset of treatment to delivery of baby | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Side effects profile â?¢ Neonatal outcome â?¢ Need for blood transfusion Timepoint: from onset of treatment to delivery of baby | — |
Countries
India
Contacts
Public ContactChanderdeep Sharma
Dr RPGMC Kangra at Tanda (HP)
Outcome results
None listed